HighTower Advisors
IMGN

HighTower Advisors’s Immunogen Inc IMGN Stock Holding History

HighTower Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,713
Closed -$77K – 3750
2021
Q4 		$77K Buy
+10,713
New +$66.6K ﹤0.01% 2974
2021
Q1 		– Sell
-10,548
Closed -$62K – 3302
2020
Q4 		$62K Sell
10,548
-945
-8% -$5.51K ﹤0.01% 2387
2020
Q3 		$31K Sell
11,493
-96,153
-89% -$388K ﹤0.01% 2339
2020
Q2 		$485K Buy
+107,646
New +$458K ﹤0.01% 1486
2019
Q4 		– Sell
-12,027
Closed -$17K – 2571
2019
Q3 		$17K Buy
12,027
+789
+7% +$2.1K ﹤0.01% 2283
2019
Q2 		$13K Buy
+11,238
New +$26.6K ﹤0.01% 2284
2019
Q1 		– Sell
-10,288
Closed -$37K – 2449
2018
Q4 		$37K Buy
+10,288
New +$62.4K ﹤0.01% 2050
2018
Q3 		– Sell
-10,857
Closed -$104K – 2448
2018
Q2 		$104K Sell
10,857
-477
-4% -$5.03K ﹤0.01% 2002
2018
Q1 		$119K Sell
11,334
-763
-6% -$7.54K ﹤0.01% 1954
2017
Q4 		$74K Sell
12,097
-1,123
-8% -$6.93K ﹤0.01% 2065
2017
Q3 		$103K Sell
13,220
-3,964
-23% -$26.3K ﹤0.01% 2020
2017
Q2 		$128K Sell
17,184
-18
-0.1% -$82 ﹤0.01% 1923
2017
Q1 		$66K Buy
17,202
+3,289
+24% +$9.6K ﹤0.01% 1901
2016
Q4 		$17K Sell
13,913
-5,548
-29% -$11.1K ﹤0.01% 1867
2016
Q3 		$45K Buy
+19,461
New +$56.6K ﹤0.01% 1792
2016
Q2 		– Sell
-17,284
Closed -$150K – 2063
2016
Q1 		$150K Sell
17,284
-860
-5% -$7.28K ﹤0.01% 1858
2015
Q4 		$242K Buy
+18,144
New +$223K ﹤0.01% 1670

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's IMGN Position: Q1 2022 in Review

HighTower Advisors sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 10,713 shares — an estimated $77K sold.

HighTower Advisors first reported a position in IMGN in Q4 2015 and held it in 17 quarters. The position peaked at $485K in Q2 2020. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • HighTower Advisors reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • HighTower Advisors sold 10,713 Immunogen Inc shares in Q1 2022, an estimated $77K.
  • HighTower Advisors first reported a position in Immunogen Inc in Q4 2015 and held it in 17 quarters.
  • HighTower Advisors's Immunogen Inc position peaked at $485K in Q2 2020.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on HighTower Advisors's 13F filing for Q1 2022, filed 12 May 2022.